Better Health for All

GE HealthCare's core business, encompassing medical imaging, diagnostics, and AI solutions, is dedicated to improving health outcomes, diagnosing diseases, and enhancing patient care, with no reported revenue from products with negative health outcomes. The company's products and services, including 72 FDA-authorized AI-enabled medical devices

and over 40 AI-enabled imaging innovations, enhance precision care, clinician support, and system efficiency, with some solutions reducing scan times by up to 50%. GE HealthCare provides AI-assisted ultrasound tools for healthcare professionals with limited experience, including on cost-effective handheld units, expanding access to quality care in underserved regions and addressing maternal and fetal health. The company also addresses physician burnout through its AI-enabled devices. GE HealthCare has established a Foundation to advance equitable access to precision healthcare, focusing on maternal and child health in underserved communities. The company does not produce food or nutritional products, nor does it have products with addiction potential.

Fair Money & Economic Opportunity

GE HealthCare Technologies Inc. is a medical technology company, not a financial institution.

The 'Fair Money & Economic Opportunity' value and its associated KPIs are designed to assess companies involved in lending, insuring, moving, or storing money, and their impact on financial inclusion and wealth building for underserved populations. As GE HealthCare does not offer these types of financial services or consumer credit products, all KPIs are deemed not applicable to its business model.

Fair Pay & Worker Respect

GE HealthCare reported achieving 100% gender pay equity and 100% pay equity for underrepresented minorities in the U.S. as of 2022.

The company also has a pay transparency policy, ensuring employees will not face discrimination for discussing pay. Additionally, 34.2% of leadership roles globally are held by women. The company acknowledges and respects employees' rights to unionize, with a newly formed bargaining unit of 130 employees at its Aurora facility. However, some employees have expressed concerns about limited pay raises and challenges in career progression. Management has been described as untrained and distant, focusing on profit over employee development, with advice for new biomedical technicians to negotiate higher starting salaries due to limited growth opportunities. A labor dispute also led to the withdrawal of some job offers to avoid supply disruptions after unsuccessful negotiations regarding a shift schedule change.

Fair Trade & Ethical Sourcing

GE HealthCare Technologies Inc. has implemented a comprehensive Supplier Responsibility Governance (SRG) program to foster an ethical, sustainable, and transparent global supply chain.

This program includes rigorous supplier selection criteria, onboarding processes, and regular audits for suppliers in high-risk regions. The company provides training on sustainability and ESG topics, with 21% of the top 70% of suppliers by spend having completed an EcoVadis assessment as of March 2024. GE HealthCare participates in the Responsible Minerals Initiative (RMI) and published its first annual report on conflict minerals, detailing due diligence for tin, tantalum, tungsten, and gold (3TG). A Reasonable Country of Origin Inquiry (RCOI) surveyed 383 significant suppliers , indicating some 3TG minerals may originate from high-risk areas , with a commitment to mitigate these risks . The company's Supplier Integrity Guide outlines ethical sourcing requirements , and an Open Reporting and Ombudsperson program allows confidential concern raising .

Honest & Fair Business

No specific, quantifiable evidence was found in the provided articles for any of the KPIs related to Honest & Fair Business. The articles discuss GE HealthCare's commitment to sustainability, including a 27% reduction in Scope 1 and 2 greenhouse gas emissions since 2019

, and compliance with data protection and privacy regulations like the Digital Personal Data Protection Bill and GDPR . The company also released its first Sustainability Report in 2023 . However, these do not provide concrete data points such as regulatory fine amounts, transparency index scores, details of a whistleblower policy, financial restatements, audit coverage percentages, ESG controversy scores, complaint resolution times, board conflict percentages, specific anti-corruption policy details, or the extent of third-party verification of ethical claims.

Kind to Animals

GE HealthCare's animal testing policy states that animals are used in research and product development only when scientifically necessary or required by regulatory authorities.

The policy adheres to the "Three Rs" principle (reduce, refine, replace). , requires all animal studies to comply with local and national regulations, including appropriate licensing requirements. , and mandates that studies are scrutinized, approved, and continuously monitored by a designated oversight committee. The company's animal welfare standards exceed statutory requirements. GE HealthCare significantly reduced its animal usage from 5,660 animals in 2009 to 658 in 2017. For its supply chain, 38% of Tier 1 suppliers' facilities participate in third-party audit programs for manufacturing and audit quality. The company's Supplier Responsibility Governance Program, implemented in 2002, includes on-site supplier audits every one to five years based on risk.

No War, No Weapons

GE HealthCare has engaged in defense-related contracts for medical equipment, including a $44 million contract in 2023 for AI-enhanced ultrasound technology with potential military use, and earlier contracts for patient monitoring systems.

These contracts represent less than 1% of the company's $19.7 billion revenue. The company has a Responsible AI Policy and Principles, but specific military safeguards for AI are not detailed. In 2024, the GE HealthCare Foundation provided $4 million in grants for community initiatives, representing approximately 0.02% of revenue. The company's supply chain includes an Ethical Supply Chain Program and Supplier Responsibility Governance program. In 2024, 63% of facilities identified by the Responsible Minerals Initiative were conformant with its assurance program. GE HealthCare annually assesses its supply chain for conflict minerals and states its commitment aligns with the UN Guiding Principles on Business and Human Rights. As a healthcare company, it is not subject to Arms Trade Treaty declarations, nor does it engage in surveillance or intelligence activities.

Planet-Friendly Business

GE HealthCare has set a target to reduce operational greenhouse gas emissions by 50% by 2030, striving for net-zero emissions by 2050.

The company has already achieved a 27% reduction in operational GHG emissions since 2019. It has also joined the White House Pledge to Decarbonize the Health Care Sector. In 2023, GE HealthCare recovered 7,375 imaging, ultrasound, and surgery machines, leading to over 15 million pounds of reused and recycled material. This effort is supported by a partnership with reLink Medical, established in October 2023, for the end-of-life management of medical devices through resale, recycling, or donation. Furthermore, the Revolution™ Apex platform incorporates energy-saving modes that reduce power consumption by approximately 80% during idle times, contributing to more than a 30% daily energy reduction.

Safe & Smart Tech

GE HealthCare emphasizes AI safety, explainability, patient safety, privacy, fairness, and transparency in its AI innovation efforts and collaborations.

The company's development processes for AI models and applications prioritize data security and patient privacy, adhering to healthcare privacy standards. Furthermore, GE HealthCare commits to updating its data protection practices to comply with the Digital Personal Data Protection Bill 2023 and global data security laws.